Warszawa, Poland

Alicja Orlowska


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alicja Orlowska: Innovator in Growth Hormone Research

Introduction: Alicja Orlowska is a notable inventor based in Warszawa, Poland, recognized for her significant contributions to the field of biochemistry and pharmaceuticals. With a focus on developing analogs of human growth hormone-releasing hormone, her innovative work has the potential to impact therapeutic treatments in notable ways.

Latest Patents: Orlowska holds a patent for "Analogs of human growth hormone-releasing hormone, their preparation and use." This invention involves a specific amino acid sequence designed to act as potent and selective stimulators of growth hormone release, showcasing high resistance to enzymatic degradation. The synthesis of these peptides involves advanced solid-phase synthesis methods, highlighting her expertise in both innovation and technical skill.

Career Highlights: Throughout her career, Alicja Orlowska has worked with esteemed companies such as Instytut Farmaceutyczny and Zakłady Farmaceutyczne Polpharma. These positions have allowed her to further advance her research and development abilities in the pharmaceutical sector, contributing to her recognition as an innovator in her field.

Collaborations: Orlowska has collaborated with professionals such as Jan Izdebski and Danuta Kunce, enhancing her research with a diverse range of ideas and methodologies. These collaborations have fostered an environment of innovation, leading to the successful development of new pharmaceutical avenues.

Conclusion: Alicja Orlowska’s contributions to the field of growth hormone research reflect her dedication and innovative spirit. Her patented work on hormone-releasing hormone analogs illustrates the potential for significant advances in medical therapies, marking her as an important figure in the realm of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…